Helpful explanatory models for somatoform symptoms (HERMES): study protocol of a randomised mixed-methods pilot trial

被引:3
|
作者
Huesing, Paul [1 ]
Loewe, Bernd [1 ]
Hartman, Tim C. Olde [2 ]
Frostholm, Lisbeth [3 ]
Weigel, Angelika [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany
[2] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands
[3] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark
来源
BMJ OPEN | 2021年 / 11卷 / 03期
关键词
psychiatry; general medicine (see internal medicine); primary care; preventive medicine; MEDICALLY UNEXPLAINED SYMPTOMS; PERSISTENT SOMATIC SYMPTOMS; BODILY DISTRESS DISORDER; CRITERIA SCALE SSD-12; PRIMARY-CARE; PATIENTS PERCEPTIONS; PHYSICAL SYMPTOMS; VALIDITY; SOMATIZATION; POPULATION;
D O I
10.1136/bmjopen-2020-044244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Persistent somatic symptoms (PSS) are common both in the general population and primary care. They are bothersome in terms of psychological and somatic symptom burden. Health professionals often struggle with communication, as there is a lack of scientifically supported explanatory models for PSS or a focus merely on somatic aspects of the complaints, which both frustrate patients' needs. The objective of the present study is therefore to develop a psychoeducational intervention based on a current evidence-based explanatory model, to examine its feasibility and form the basis for a large-scale randomised controlled trial. Methods and analysis In a randomised controlled mixed-methods pilot trial, 75 adult psychosomatic outpatients with PSS (duration of symptoms >= 6 months) and accompanying psychological (Somatic Symptom B-Criteria Scale total score >= 18) and somatic symptom burden (Patient Health Questionnaire-15 score >10) and no prior psychosomatic treatment will be eligible. Participants will be presented with either the explanatory model without (intervention group 1, n=25) or with elements of personalisation (intervention group 2, n=25). Participants in the control group (n=25) will receive information on current PSS guidelines. Participants will be blinded to group assignment and interventions will be shown on tablet computers at the outpatient clinic. After 1 month, qualitative follow-up telephone interviews will be conducted. As primary outcomes, mean changes in psychological and somatic symptom burden will quantitatively be compared between groups, respectively. Behavioural change mechanisms and feasibility of the three interventions will be evaluated using quantitative and qualitative measures. Ethics and dissemination Ethics approval has been granted by the medical ethics board of the Hamburg Medical Chamber (PV5653). Results from this study will be published in peer-reviewed journals and presented at national and international conferences.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Helpful explanatory models for persistent somatic symptoms: a randomized controlled pilot study (HERMES)
    Weigel, A.
    Huesing, P.
    Loewe, B.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 157
  • [2] Helpful explanatory models of persistent body complaints: Results of a pilot experimental study (HERMES)
    Weigel, A.
    Huesing, P.
    Loewe, B.
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2022, 68 (02): : 212 - 212
  • [3] Helpful explanatory models for persistent somatic symptoms (HERMES): Results of a three-arm randomized-controlled pilot trial
    Weigel, Angelika
    Huesing, Paul
    Junge, Magdalena
    Loewe, Bernd
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2023, 172
  • [4] Helpful Explanatory Models for persistent Body Complaints: Study Protocol of an experimental Pilot Study
    Weigel, Angelika
    Huesing, Paul
    Loewe, Bernd
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2019, 66 (01): : 121 - 121
  • [5] Paradoxical intention as a treatment for insomnia disorder: study protocol for a mixed-methods pilot trial
    Salim, Osame
    Jansson-Frojmark, Markus
    Sandlund, Christina
    Norell, Annika
    BMJ OPEN, 2024, 14 (10):
  • [6] A Pilot Mixed-Methods Study of Malignant Pleural Mesothelioma Symptoms
    Walker, Suzanne L.
    Dickson, Victoria Vaughan
    Cacchione, Pamela Z.
    ONCOLOGY NURSING FORUM, 2022, 49 (06) : 615 - 623
  • [7] Intimate partner violence after childbirth: an explanatory sequential mixed-methods study protocol
    Ghelichkhani, Fatemeh
    Moghadam, Zahra Behboodi
    Zareiyan, Armin
    Namazi, Masoumeh
    REPRODUCTIVE HEALTH, 2024, 21 (01)
  • [8] IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial
    Stagg, Helen R.
    Abubakar, Ibrahim
    Campbell, Colin N. J.
    Copas, Andrew
    Darvell, Marcia
    Horne, Robert
    Kielmann, Karina
    Kunst, Heinke
    Mandelbaum, Mike
    Pickett, Elisha
    Story, Alistair
    Vidal, Nicole
    Wurie, Fatima B.
    Lipman, Marc
    BMJ OPEN, 2019, 9 (12):
  • [9] Qualitative evaluation of an explanatory model for somatoform symptoms (HERMES study): Acceptance and feasibility of a video-animated intervention
    Huesing, P.
    Loewe, B.
    Junge, M.
    Weigel, A.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2020, 133
  • [10] Mobilisation in the EveNing to TreAt deLirium (MENTAL): protocol for a mixed-methods feasibility randomised controlled trial
    McWilliams, David
    King, Elizabeth
    Nydahl, Peter
    Darbyshire, Julie Lorraine
    Gallie, L.
    Barghouthy, Dalia
    Bassford, C.
    Gustafson, Owen
    BMJ OPEN, 2023, 13 (02):